Condition

Lymphoma, Non-Hodgkin clinical trials and research

• 29Clinical trials
• 22Countries

Newest Lymphoma, Non-Hodgkin clinical trials

All recruiting trials (29)

• JMBI-001 in MYC-Positive Advanced Cancers

  This study tests JMBI-001 to see if it is safe and tolerable for adults with MYC-positive advanced cancers.

  Recruiting Phase 1/2 Chengdu Anticancer Bioscience, Ltd. · Beijing, Beijing Municipality · NCT07864701

• UB-VV400 with rapamycin in relapsed/refractory B-cell lymphomas

  A phase 1/2 trial tests UB-VV400 plus rapamycin in adults with relapsed or refractory B-cell lymphomas to see if it is safe and shows anti-tumor activity.

  Recruiting at 2 sites Phase 1/2 Umoja Biopharma · Irvine, California and 1 other locations · NCT07735533

• Toxin exposure and immune factors in B-cell non-Hodgkin lymphoma

  This study tests how toxin exposure, genetics, and immune issues relate to B-cell non-Hodgkin lymphoma in active-duty service members and other Military Health System beneficiaries.

  Recruiting Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland and 2 other locations · NCT07652580

• GSK5926371 in adults with relapsed or refractory B-cell non-Hodgkin lymphoma

  We’re testing whether GSK5926371 is safe and can show activity in adults whose B-cell non-Hodgkin lymphoma has come back or not responded to prior treatment.

  Recruiting at 22 sites Phase 1/2 GlaxoSmithKline · Iowa City, Iowa and 21 other locations · NCT07607925

• AI tool to spot and reduce missed doses of oral medicines for Non-Hodgkin lymphoma patients

  This project will try an AI-based system to detect early risks of not taking prescribed oral treatments and alert clinicians for adults with Non-Hodgkin lymphoma treated at Grand Hôpital de Charleroi.

  Recruiting Grand Hôpital de Charleroi · Charleroi, Hainaut · NCT07546188

• MK-1045 for follicular lymphoma and diffuse large B-cell lymphoma

  This trial tests MK-1045 in people with follicular lymphoma or diffuse large B-cell lymphoma to see if the treatment is safe and tolerable and whether the cancer shrinks or disappears.

  Recruiting at 54 sites Phase 1/2 Merck Sharp & Dohme LLC · Los Angeles, California and 53 other locations · NCT07519772

• Electronic mindfulness-based music therapy for patients receiving stem cell transplantation

  This trial tests an eHealth mindfulness-based music therapy to see if it improves quality of life and reduces symptoms for adults undergoing stem cell transplantation.

  Recruiting University of Miami · Miami, Florida · NCT07469592

• JNJ-95566692 alone or with JNJ-87801493 for relapsed or refractory B‑cell non‑Hodgkin lymphoma

  This trial tests whether the drug JNJ-95566692, given alone or with JNJ-87801493, helps people with relapsed or refractory B‑cell non‑Hodgkin lymphoma who have had prior therapies.

  Recruiting at 19 sites Phase 1 Janssen Research & Development, LLC · Clayton and 18 other locations · NCT07308132

• New therapy dose test for people with prior B-cell cancers

  This early-phase study tests different doses of LY4152199 to see if it is safe and effective for people who have already been treated for certain B-cell lymphomas.

  Recruiting at 25 sites Phase 1 Eli Lilly and Company · Duarte, California and 50 other locations · NCT07101328

• TLN-121 for relapsed or refractory non-Hodgkin lymphoma

  We will test TLN-121 by itself and together with other lymphoma treatments in people whose non-Hodgkin lymphoma has returned or did not respond to prior therapies.

  Recruiting at 14 sites Phase 1 Treeline Biosciences, Inc. · Palo Alto, California and 13 other locations · NCT07082803

• Breaking up long sitting periods to improve heart health and reduce chemo side effects in adults with lymphoma on R-CHOP or POLA-R-CHP

  This trial will test whether a 12-week program that interrupts long periods of sitting helps newly diagnosed adults with lymphoma receiving R-CHOP or POLA-R-CHP chemotherapy improve heart health and reduce chemotherapy side effects.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT06923397

• Collecting data on cellular immunotherapy for lymphoma patients

  This study is gathering information from adults with relapsed or hard-to-treat non-Hodgkin's lymphoma who are getting cellular immunotherapy to see how well it works and how safe it is.

  Recruiting Ruijin Hospital · Shanghai · NCT06541327

• Epcoritamab treatment for certain types of lymphoma

  This study is testing if adding a new treatment called epcoritamab to CAR T cell therapy can help people with certain types of lymphoma who haven't fully responded to previous treatments.

  Recruiting Phase 2 Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT06458439

• T-Cell Therapy for Adults with Relapsed B-Cell Non-Hodgkin's Lymphoma

  This study is testing a new T-cell therapy to see if it can help adults with relapsed B-cell non-Hodgkin's lymphoma feel better.

  Recruiting at 5 sites Phase 1/2 Estrella Immunopharma, Inc. · Sacramento, California and 4 other locations · NCT06343311

• Using a connected scale to monitor weight and vitals during lymphoma and myeloma treatment

  This project will test whether daily use of a connected scale to track weight and heart rate at home can help people with lymphoma or multiple myeloma who are receiving chemotherapy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06133426

• CD19-directed CAR-T cell therapy for relapsed leukemia and lymphoma

  This study is testing a new CAR-T cell therapy to see if it can help people with hard-to-treat leukemia and lymphoma feel better.

  Recruiting at 5 sites Phase 1/2 University of Sao Paulo · Campinas, São Paulo and 4 other locations · NCT06101381

• Treatment of B-cell malignancies with ALETA-001

  This study is testing a new treatment called ALETA-001 to see if it can help people with relapsed non-Hodgkin lymphoma who didn't respond well to previous therapies.

  Recruiting at 6 sites Phase 1/2 Cancer Research UK · Birmingham and 6 other locations · NCT06045910

• Testing ONM-501 alone and with Cemiplimab for advanced solid tumors and lymphomas

  This study is testing a new treatment called ONM-501, both alone and with another drug called cemiplimab, to see if it can help people with advanced solid tumors and lymphomas who have run out of other treatment options.

  Recruiting at 5 sites Phase 1 OncoNano Medicine, Inc. · Los Angeles, California and 15 other locations · NCT06022029

• Depleting specific immune cells in stem cell transplants for blood cancers

  This study is testing if removing certain immune cells during stem cell transplants can help children and young adults with blood cancers have better outcomes and fewer complications.

  Recruiting Phase 2 University of Florida · Gainesville, Florida · NCT05800210

• New CAR T-cell therapy for children and young adults with certain blood cancers

  This study is testing a new CAR T-cell therapy that uses modified cells from children's and young adults' own blood to see if it can help treat certain tough-to-treat blood cancers.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05442515

• Fecal Microbiota Transplantation to Prevent Complications After Stem Cell Transplantation

  This study is testing whether giving a special stool treatment can help prevent complications like Graft-versus-Host Disease in patients receiving stem cell transplants for blood cancers.

  Recruiting at 3 sites Phase 2 University Hospital, Clermont-Ferrand · Amiens and 19 other locations · NCT04935684

• Evaluating a combined pneumococcal vaccination for patients with acute leukemia or lymphoma

  This study is testing a new combined pneumonia vaccine to see if it helps people with acute leukemia or lymphoma who are getting chemotherapy stay healthier and avoid serious infections.

  Recruiting at 5 sites Phase 4 Poitiers University Hospital · Angers and 6 other locations · NCT04460235

• Targeted therapy for advanced cancers based on genetic profiling

  This study is testing whether targeted treatments based on the genetic makeup of advanced cancers can help patients with conditions like non-Hodgkin lymphoma and multiple myeloma feel better and have more effective options.

  Recruiting at 10 sites Phase 2 Canadian Cancer Trials Group · Edmonton, Alberta and 9 other locations · NCT03297606

• Cohort study for patients with aggressive lymphoma

  This study looks at patients with aggressive lymphoma to see how well standard treatments work and how the disease changes over time.

  Recruiting Samsung Medical Center · Seoul · NCT03117036

• Using FDA-approved drugs to target specific tumor gene abnormalities in advanced cancer patients

  This study is testing if certain FDA-approved drugs can help advanced cancer patients with specific gene changes feel better when standard treatments haven't worked.

  Recruiting at 153 sites Phase 2 American Society of Clinical Oncology · Birmingham, Alabama and 180 other locations · NCT02693535

• Collecting biospecimens for cancer research

  This study is collecting blood and tumor samples from adults with cancer to help researchers learn more about the disease and improve treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT02682667

• Collecting tissue samples to study lymph cancer

  This study is collecting tissue samples from people with lymphoid cancers to learn more about the disease and help create better treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT01676805

• Study of family connections in blood and lymph cancers

  This study looks at families with multiple members diagnosed with blood and lymph cancers to see if genetics and environmental factors play a role in their development.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT00626496

• Research on tumor cells in lymphoma

  This study is trying to learn more about tumor cells in people with Hodgkin's disease and non-Hodgkin's lymphoma to help develop better treatments and ways to track how well current treatments are working.

  Recruiting Stanford University · Stanford, California · NCT00398177

Related topics

Quick answers

How many Lymphoma, Non-Hodgkin clinical trials are recruiting right now?

29, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in United States (18 trials), France (7 trials), Australia (6 trials), Canada (5 trials), Spain (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 8, Phase 2: 5, Phase 1: 4, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →